Experimental Anticancer PARP Inhibitors Slow Cisplatin-resistant Non-small Cell Lung Cancer (NSCLC)
Everyone's Blog Posts - Onco'Zine,
Drugs classified as poly (ADP-ribose) polymerase (PARP) inhibitors have been shown to be promising anticancer agents for breast…